PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma-Reference-Cited by-同舟云学术

PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma

Published:2006-11 Issue:11 Volume:30 Page:1333-1339
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Proto-Siqueira Rodrigo,Figueiredo-Pontes Lorena L.,Panepucci Rodrigo A.,Garcia Aglair B.,Rizzatti Edgar G.,Nascimento Fabio M.,Ishikawa Hellen C.F.,Larson Roy E.,Falcão Roberto P.,Simpson Andrew J.,Gout Ivan,Filonenko Valery,Rego Eduardo M.,Zago Marco A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor;Ikeda;Immunity,1997

2. PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells;van Baren;Br J Haematol,1998

3. Genes encoding tumor-specific antigens are expressed in human myeloma cells;van Baren;Blood,1999

4. The expression of PRAME in chronic lymphoproliferative disorders;Proto-Siqueira;Leukemia Res,2003

5. Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo;Tajeddine;Cancer Res,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PRAME for acute myeloid leukemia therapy;Frontiers in Immunology;2024-03-26

2. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer;Cells;2023-03-17

3. Aminooxy Click Modification of a Periodate-Oxidized Immunoglobulin G: A General Approach to Antibody–Drug Conjugates with Dye-Mediated Expeditious Stoichiometry Control;International Journal of Molecular Sciences;2023-03-07

4. Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients;Journal of Genetic Engineering and Biotechnology;2022-07-05

5. Development of a Humanized Antibody 5D3Hu against the PRAME Tumor Antigen;Russian Journal of Bioorganic Chemistry;2022-04